| |
|
|
|
Entera Bio Ltd.  
|
|
4.28 0.08 (0.02%) |
04-22 09:30 |
|
Open: |
4.29 |
Pre close: |
4.2 |
Target:
|
5.14
|
|
High: |
4.29 |
Low: |
4.28 |
Resistance:
|
4.40
5.14
|
|
Volume: |
1,100 |
Market Cap: |
49M |
Support:
|
4.02
3.79
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.18
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
4.16 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
4.15  |
Stochastic Oscillator |
%K(14,3):
|
75.04 |
|
MA(250): |
0.00 |
%D(3): |
60.35 |
|
Average Volume(K) |
3-Month: |
2007
|
52-Week |
High:
|
6.95 |
|
10-Days: |
718 |
Low: |
2.55 |
|
RSI |
RSI(14):
|
52.50 |
Change(%): |
-31.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
96.1 |
Shares Out. (M) |
11.46 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-77.4 |
Shares Float (M) |
11.46 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.90 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.840 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.80 |
P/S |
817480000.00 |
|
Operating Margin |
-2172.20 |
Levered Free Cash Flow
(M) |
-5.81 |
P/CF |
-5.00 |
|
|
|
|
|
|
